Brasada Capital Management LP Purchases New Position in Danaher Corporation $DHR

Brasada Capital Management LP purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 8,551 shares of the conglomerate’s stock, valued at approximately $1,629,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. FSA Advisors Inc. acquired a new stake in shares of Danaher in the 2nd quarter valued at $269,000. N10 Assets LLC acquired a new stake in shares of Danaher during the 2nd quarter worth about $7,208,000. Coastal Bridge Advisors LLC acquired a new stake in shares of Danaher during the 2nd quarter worth about $490,000. Jefferies Financial Group Inc. bought a new position in Danaher during the 2nd quarter valued at about $1,586,000. Finally, Public Employees Retirement System of Ohio bought a new position in Danaher during the 2nd quarter valued at about $41,194,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 0.2%

DHR opened at $215.74 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $151.67 billion, a PE ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a 50-day moving average price of $198.69 and a two-hundred day moving average price of $192.35.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on DHR. Citigroup initiated coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective on the stock. HSBC cut their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, Royal Bank Of Canada raised their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $228.91.

View Our Latest Research Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.